echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > In order to expand production capacity and optimize production processes, the pharmaceutical company plans to invest 150 million overseas

    In order to expand production capacity and optimize production processes, the pharmaceutical company plans to invest 150 million overseas

    • Last Update: 2022-01-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    On January 12, Jiudian Pharmaceutical announced that it plans to invest 157 million yuan to build the construction project (Phase I) of Jiudian Pharmaceutical's high-end formulation research and development industrial park on Jiankang Avenue in Liuyang Economic Development Zone
    The announcement shows that the purpose of this foreign investment has two aspects

    On the one hand, it is conducive to expanding product production capacity to meet the rapidly growing market demand

    With the rapid growth of the sales scale of the company's external preparation products, the production capacity of the existing production lines has been difficult to match with the rapidly growing market demand.
    Gel patch production capacity

    On the other hand, it is also conducive to optimizing the production process, reducing production costs and improving product quality

    This project plans to build a production base for external preparation products.
    Through more reasonable and efficient configuration of various production materials, the production process of loxoprofen sodium gel patch and ketoprofen gel patch can be effectively optimized, thereby greatly improving the At the same time, the introduction of domestic and foreign inspection and testing equipment and high-quality testing personnel, strengthen and improve the drug production quality management system, and effectively ensure the quality and safety of drugs

    Regarding the impact of this new project on the company, Jiudian Pharmaceutical stated in the announcement that it will further optimize the production process of external preparation products, reduce production costs, and improve product quality and performance, which will help further enhance the company's core competitiveness and promote The company is developing rapidly

    In addition, this project complies with the requirements of the national industrial policy for the development of the industry, and through the implementation of reasonable and controllable environmental protection measures, the project construction and operation will have less impact on the environment

    At the same time, the project has good expected financial benefits, can improve the overall profitability of the company, and has positive significance for promoting local employment and tax growth

    It is worth mentioning that on the same day, Jiudian Pharmaceutical also issued another announcement.
    In order to make better use of the raised funds, improve the quality of fundraising projects, and optimize the allocation of resources, the company has added a new site for the implementation of the expansion construction project of the external preparation workshop.
    , adjusted the construction period

    Among them, the project implementation location was adjusted from "the first floor of the existing factory complex building, No.
    1 Jianjian Avenue, Liuyang Economic and Technological Development Zone" to "the first floor of the existing factory complex building, No.
    1 Jianjian Avenue, Liuyang Economic and Technological Development Zone, and Liuyang Economic and Technological Development Zone.
    Health Avenue" , the construction period was also adjusted from 12 months to 32 months

    As of the disclosure date of this announcement, the implementation site of the above-mentioned newly raised investment projects has been approved by the Changsha Municipal Bureau of Ecology and Environment

    According to the data, Jiudian Pharmaceutical is a listed pharmaceutical company integrating drug research and development, production and sales.
    The company was incorporated in 2001 and listed on the Growth Enterprise Market in 2017

    The company's products mainly include four categories: pharmaceutical preparations, APIs, pharmaceutical excipients and plant extracts

    The company adheres to the development of "formulation-API-pharmaceutical excipients integration" to create vertical integration advantages.
    At present, it has completed the industrial layout of pharmaceutical preparations, traditional Chinese medicines, APIs, pharmaceutical excipients, and pharmaceutical business.
    It has APIs and oral solid preparations.
    , Oral liquid preparations, gel ointments, pharmaceutical excipients and other modern production lines

    According to the company's financial report for the first half of 2021, the company's revenue and profits in the first half of 2021 mainly come from pharmaceutical preparations, accounting for 83.
    4% of revenue

    The sales scale of various pharmaceutical preparations of the company has increased year by year, among which loxoprofen sodium gel patch, ornidazole tablets and dispersible tablets, levocetirizine hydrochloride tablets and capsules, dirithromycin enteric-coated tablets, etc.
    Sales are at the top, and the competitive position in the industry is becoming increasingly prominent

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.